|
1421 |
Testing for benzodiazepine inebriation—relationship between benzodiazepine concentration and simple clinical tests for impairment in a sample of drugged drivers
Enthalten in European journal of clinical pharmacology Bd. 59, 20.9.2003, Nr. 8-9, date:11.2003: 593-601
|
|
|
|
1422 |
The 1,4-benzodiazepine Ro5-4864 (4-chlorodiazepam) suppresses multiple pro-inflammatory mast cell effector functions
Enthalten in Cell communication and signaling Bd. 11, 20.2.2013, Nr. 1, date:12.2013: 1-15
|
|
|
|
1423 |
The association between benzodiazepine co-prescription, opioid agonist treatment and mortality: a systematic review
Enthalten in BMC psychiatry Bd. 24, 28.10.2024, Nr. 1, date:12.2024: 1-12
|
|
|
|
1424 |
The association between benzodiazepine use and sleep quality in residential aged care facilities: a cross-sectional study
Enthalten in BMC geriatrics Bd. 16, 26.11.2016, Nr. 1, date:12.2016: 1-9
|
|
|
|
1425 |
The COVID-19 pandemic and the use of benzodiazepines and benzodiazepine-related drugs in Estonia: an interrupted time-series analysis
Enthalten in Child and adolescent psychiatry and mental health Bd. 18, 6.6.2024, Nr. 1, date:12.2024: 1-10
|
|
|
|
1426 |
The effect of non-benzodiazepine hypnotics on sleep quality and severity in patients with OSA: a meta-analysis
Enthalten in Sleep and breathing Bd. 18, 29.1.2014, Nr. 4, date:12.2014: 781-789
|
|
|
|
1427 |
The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario
Enthalten in Harm reduction journal Bd. 14, 26.1.2017, Nr. 1, date:12.2017: 1-9
|
|
|
|
1428 |
The Neurochemical Mechanisms of the Pharmacological Activities of Inverse Agonists of the Benzodiazepine Binding Site
Enthalten in Neurochemical journal Bd. 12, 15.12.2018, Nr. 4, date:10.2018: 337-346
|
|
|
|
1429 |
The Pharmacology and Mechanisms of Action of New Generation, Non-Benzodiazepine Hypnotic Agents
Enthalten in CNS drugs Bd. 18, 29.8.2012, Nr. 1, date:11.2004: 9-15
|
|
|
|
1430 |
The Pharmacology of Imepitoin: The First Partial Benzodiazepine Receptor Agonist Developed for the Treatment of Epilepsy
Enthalten in CNS drugs Bd. 28, 20.12.2013, Nr. 1, date:1.2014: 29-43
|
|
Administration
